Diseases, Conditions, Syndromes

Lab boost for precious anti-malaria drug

US scientists on Wednesday said they had used baker's yeast to make a key ingredient of malaria drugs, a feat that could iron out fluctuations in supply caused by sourcing the chemical from a Chinese herb.

Medications

Bayer 'disappointed' after losing India patent fight

Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.

Vaccination

Pharma industry urges fairer vaccine access in future

The pharmaceutical industry on Tuesday proposed a system to allow for more equitable access to vaccines and treatments in future pandemics, saying it was willing to set aside doses to distribute to lower-income countries.

Medical economics

What will it take to boost Africa's vaccine production?

The COVID-19 pandemic has highlighted the importance of vaccines in controlling infectious disease in sub-Saharan Africa and renewed interest in vaccine research and development across the continent.

Diseases, Conditions, Syndromes

World could have prevented COVID catastrophe: pandemic panel

The catastrophic scale of the COVID-19 pandemic could have been prevented, an independent global panel concluded Wednesday, but a "toxic cocktail" of dithering and poor coordination meant the warning signs went unheeded.

Other

Peer review option proposed for biodiversity data

Data publishers should have the option of submitting their biodiversity datasets for peer review, according to a discussion paper commissioned by the Global Biodiversity Information Facility (GBIF).

page 5 from 9